KKKlara Kropivšek

Klara Kropivšek

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Klara Kropivšek has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    OAS-nano: the Observed VHH Space Database

    by Clare M C Gillis, Klara Kropivšek Brumat, Ario de Marco, Olga Obrezanova, Erwin De Genst, Rebecca Croasdale-Wood, Charlotte M Deane, Matthew I J Raybould

    VHHs, the variable regions of camelid heavy-chain antibodies, are increasingly used as therapeutic, diagnostic, and research tools because of their small size and stability. Despite the growing number of publicly available VHH repertoire sequencing studies, there is no large-scale, web-accessible database of VHH sequences. Here, we present OAS-nano, a database containing over 73 million unique VHH sequences collected from 16 public repertoire sequencing datasets and 1 previously unpublished dataset, spanning alpaca, llama, and Bactrian camel repertoires. Sequence reads were processed using a standardized pipeline to extract high-quality VHH sequences. Experimental metadata and sequence annotations enable users to identify sequences appropriate for their use case. OAS-nano is freely available at https://oas-nano.opig.stats.ox.ac.uk/.

  • Top Cited Papers
    Open Access

    Structural Plausibility Without Binding Specificity: Limits of AI-Based Antibody-Antigen Structure Prediction Confidence Scores

    by Eva Smorodina, Montader Ali, Klara Kropivšek Brumat, Leonardo Salicari, Samo Miklavc, Aibek Kappassov, Chengcheng Fu, Pietro Sormanni, Ario de Marco, Victor Greiff

    Antibody-antigen binding prediction remains a central challenge for AI-driven therapeutic discovery, particularly in discriminating cognate interactions from structurally plausible but incorrect pairings. We present a controlled, AI-method- and antibody-format-agnostic evaluation framework that measures binding specificity under realistic conditions. Using 106 experimentally determined single-chain antibody (nanobody)-antigen complexes and 11,342 shuffled non-cognate pairings, we benchmarked publicly-available state-of-the-art structure prediction methods (AlphaFold3, Boltz-2, Chai-1). Although the methods tested often generated geometrically plausible complexes, internal confidence metrics (ipTM) frequently failed to discriminate correct from incorrect pairings. Increased sampling improved structural refinement but not pairing discrimination, indicating that computational resources are better allocated across independent seeds and explicit negative controls. We conclude that internal confidence scores are not inherently calibrated to binding specificity and require validation against realistic decoys. To enable community benchmarking and method development, we release ∼1.8 million AI-generated complex structures and guidance for the benchmarks ahead.


  • Open Access

    Weak evidence for heritable changes in response to selection by aphids in Arabidopsis accessions

    by Marc W Schmid, Klara Kropivšek, Samuel E Wuest, Bernhard Schmid, Ueli Grossniklaus

    In plants, transgenerational inheritance of certain epialleles has been observed but experimental evidence for selection of epigenetic variation independent of genetic variation is scarce. We extended an experiment simulating selection in response to herbivory in Arabidopsis thaliana to assess a potential contribution of epigenetic variation to the selected phenotypes within three accessions. To minimize maternal effects, we grew offspring from replicate populations and their ancestors for two generations in a common environment and assessed the phenotypes in the second generation. We found weak evidence for the selection of epigenetic variation: bolting time differed significantly in one accession. Significant differences between maternal lines suggested random residual or novel genetic and/or epigenetic variation. Our results are in conflict with those of a recent study reporting that environment-induced heritable variation is common in Arabidopsis. Reanalyzing the data from that study showed that the reported findings resulted from a mix-up of accessions and, thus, reflected genetic rather than epigenetic variation between accessions. To avoid future misinterpretations of studies investigating epigenetic inheritance, we provide guidelines to design experiments that clearly differentiate between epigenetic and genetic variation and distinguish standing variation from de novo variation acquired during an experiment.


  • Open Access

    Weak evidence for heritable changes in response to selection by aphids in Arabidopsis accessions

    by Marc W Schmid, Klara Kropivšek, Samuel E Wuest, Bernhard Schmid, Ueli Grossniklaus

    In plants, transgenerational inheritance of certain epialleles has been observed but experimental evidence for selection of epigenetic variation independent of genetic variation is scarce. We extended an experiment simulating selection in response to herbivory in Arabidopsis thaliana to assess a potential contribution of epigenetic variation to the selected phenotypes within three accessions. To minimize maternal effects, we grew offspring from replicate populations and their ancestors for two generations in a common environment and assessed the phenotypes in the second generation. We found weak evidence for the selection of epigenetic variation: bolting time differed significantly in one accession. Significant differences between maternal lines suggested random residual or novel genetic and/or epigenetic variation. Our results are in conflict with those of a recent study reporting that environment-induced heritable variation is common in Arabidopsis. Reanalyzing the data from that study showed that the reported findings resulted from a mix-up of accessions and, thus, reflected genetic rather than epigenetic variation between accessions. To avoid future misinterpretations of studies investigating epigenetic inheritance, we provide guidelines to design experiments that clearly differentiate between epigenetic and genetic variation and distinguish standing variation from de novo variation acquired during an experiment.


  • Open Access

    Weak evidence for heritable changes in response to selection by aphids in Arabidopsis accessions

    by Marc W. Schmid, Klara Kropivšek, Samuel E. Wuest, Bernhard Schmid, Ueli Grossniklaus

    In plants, transgenerational inheritance of certain epialleles has been observed but experimental evidence for selection of epigenetic variation independent of genetic variation is scarce. We extended an experiment simulating selection in response to herbivory in Arabidopsis thaliana to assess a potential contribution of epigenetic variation to the selected phenotypes within three accessions. To minimize maternal effects, we grew offspring from replicate populations and their ancestors for two generations in a common environment and assessed the phenotypes in the second generation. We found weak evidence for the selection of epigenetic variation: bolting time differed significantly in one accession. Significant differences between maternal lines suggested random residual or novel genetic and/or epigenetic variation. Our results are in conflict with those of a recent study reporting that environment-induced heritable variation is common in Arabidopsis . Reanalyzing the data from that study showed that the reported findings resulted from a mix-up of accessions and, thus, reflected genetic rather than epigenetic variation between accessions. To avoid future misinterpretations of studies investigating epigenetic inheritance, we provide guidelines to design experiments that clearly differentiate between epigenetic and genetic variation and distinguish standing variation from de novo variation acquired during an experiment.


  • Open Access

    Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma

    by Klara Kropivsek, Paul Kachel, Sandra Goetze, Rebekka Wegmann, Yasmin Festl, Yannik Severin, Benjamin D. Hale, Julien Mena, Audrey van Drogen, Nadja Dietliker, et al.

    Multiple myeloma (MM) is a plasma cell malignancy defined by complex genetics and extensive patient heterogeneity. Despite a growing arsenal of approved therapies, MM remains incurable and in need of guidelines to identify effective personalized treatments. Here, we survey the ex vivo drug and immunotherapy sensitivities across 101 bone marrow samples from 70 patients with MM using multiplexed immunofluorescence, automated microscopy and deep-learning-based single-cell phenotyping. Combined with sample-matched genetics, proteotyping and cytokine profiling, we map the molecular regulatory network of drug sensitivity, implicating the DNA repair pathway and EYA3 expression in proteasome inhibitor sensitivity and major histocompatibility complex class II expression in the response to elotuzumab. Globally, ex vivo drug sensitivity associated with bone marrow microenvironmental signatures reflecting treatment stage, clonality and inflammation. Furthermore, ex vivo drug sensitivity significantly stratified clinical treatment responses, including to immunotherapy. Taken together, our study provides molecular and actionable insights into diverse treatment strategies for patients with MM.